US 6369235
Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection
expired A61PA61P31/18A61P37/04
Quick answer
US patent 6369235 (Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P31/18, A61P37/04, A61P43/00